What are GLP-1 medications?
GLP-1 receptor agonists (glucagon-like peptide-1) are a class of medications originally developed for type 2 diabetes that were found to produce significant, sustained weight loss. The two dominant drugs — semaglutide and tirzepatide — have reshaped obesity medicine more than any pharmacological development in decades.
Semaglutide is the active ingredient in Ozempic (approved for diabetes) and Wegovy (approved for chronic weight management). Tirzepatide is the active ingredient in Mounjaro (diabetes) and Zepbound (weight management). Both are injectable medications administered weekly by subcutaneous injection into the abdomen, thigh, or upper arm.
Semaglutide vs tirzepatide
Semaglutide acts on GLP-1 receptors only. Tirzepatide acts on both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors — a dual mechanism that produces stronger appetite suppression and metabolic effects in clinical trials.
In head-to-head data, tirzepatide outperforms semaglutide for average weight loss (20–22% body weight vs 15% for semaglutide at maximum doses). But tirzepatide also typically costs more and has more limited data in the compounded form. For most patients, semaglutide is the right starting point — it's well-studied, widely available, and significantly cheaper through compounding pharmacies.
Compounded vs brand-name GLP-1s
Brand-name GLP-1 medications (Wegovy, Zepbound) retail at $1,000–$1,500/mo without insurance. Compounded versions — prepared by licensed 503A or 503B pharmacies using the same active ingredient — cost $99–$400/mo through telehealth clinics.
Compounded medications are not FDA-approved as finished products (the FDA approves the active pharmaceutical ingredient, not the compounded formulation). This is the standard regulatory framework for all compounded medications. They are legal and widely prescribed when from a licensed pharmacy.
The FDA has raised concerns about quality control at some compounding facilities — not about compounded semaglutide in general, but about specific pharmacies. The clinics on ClinicLayer partner with pharmacies that meet USP standards and have passed state board inspections.
How GLP-1s work for weight loss
GLP-1 receptor agonists suppress appetite through multiple mechanisms: they slow gastric emptying (food stays in your stomach longer, so you feel full sooner and longer), reduce hunger signals from the brain's appetite center, and affect reward pathways that drive food cravings and "food noise" — the constant preoccupation with eating that many people experience.
The result is significantly reduced caloric intake without the willpower battle. Most patients report not needing to consciously restrict food — they simply don't want as much. The drugs don't eliminate appetite entirely; they normalize the hunger signals that obesity and insulin resistance can dysregulate.
Realistic results and timeline
| Timeframe | Typical results |
|---|---|
| Week 1–4 | Appetite reduction, nausea (common, usually temporary), early weight loss of 2–5 lbs |
| Month 1–3 | Consistent weight loss of 1–2 lbs/week on average. Food noise significantly reduced. |
| Month 3–6 | 10–15% body weight loss on track. Dose often titrated upward for continued effect. |
| Month 6–12 | Peak effects: 15–20%+ body weight reduction on semaglutide. Plateau may begin. |
Results depend heavily on adherence, dose titration, and lifestyle factors. GLP-1s are significantly more effective when combined with dietary changes and activity — not because the drug doesn't work alone, but because the combination produces more durable results than either alone.
Side effects and safety
The most common side effects are gastrointestinal: nausea, vomiting, diarrhea, and constipation. These are typically worst during dose escalation and improve over time. Starting at a low dose and titrating slowly significantly reduces GI side effects — many clinics now offer microdosing protocols for this reason.
GLP-1s carry an FDA boxed warning about thyroid C-cell tumors observed in animal studies. This has not been confirmed in humans, but the medications are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Pancreatitis has been reported rarely — discontinue and seek care if severe abdominal pain develops.
What GLP-1 costs online in 2026
Online compounded GLP-1 programs range from $99/mo (Zealthy entry-level) to $400/mo for premium tirzepatide plans. Most quality compounded semaglutide programs run $150–$250/mo all-in.
How to get GLP-1 online
- Complete an intake questionnaire — most clinics ask about your BMI, health history, and goals.
- Virtual consultation — a licensed provider reviews your information and determines eligibility. Most patients with a BMI of 30+ (or 27+ with a weight-related condition) qualify.
- Prescription and fulfillment — the prescription goes to a licensed compounding pharmacy. Medication ships to your door within 5–7 business days.
- Dose titration — you'll start at a low dose and titrate upward over several weeks to minimize side effects.
- Ongoing care — monthly check-ins to assess progress, manage side effects, and adjust dosing.
Take our quiz → to find the GLP-1 clinic that fits your budget, coaching preferences, and program length.
Frequently asked questions
How much weight can I expect to lose on semaglutide?
Clinical trials for Wegovy (semaglutide 2.4mg weekly) showed an average weight loss of approximately 15% of body weight over 68 weeks when combined with lifestyle intervention. Real-world results vary — some patients lose more, some less, depending on dose, adherence, diet, and individual metabolic response. Tirzepatide (Zepbound) showed even stronger results in trials, with average losses of 20–22% at maximum dose. These are averages from FDA-approved formulations; compounded versions use the same active ingredients but individual results vary.
Is compounded semaglutide safe?
Compounded semaglutide from licensed 503A or 503B pharmacies is legal and generally considered safe when from a quality-controlled facility. The active pharmaceutical ingredient (semaglutide) is the same as in brand-name products. The FDA's concerns have been about specific bad actors in the compounding space, not about compounded semaglutide as a category. All clinics listed on ClinicLayer work with pharmacies that meet state board inspection requirements. Check that your clinic discloses which pharmacy fills your prescription and verifies it's state-licensed.
Do I need insurance for GLP-1 medications online?
No. All compounded GLP-1 programs operate on a cash-pay model — no insurance required or accepted for the compounded medication. Some clinics (like Midi Health and Fridays) offer insurance navigation for brand-name medications, but most patients use compounded versions for cost reasons. HSA and FSA funds are typically eligible for compounded prescription medications and telehealth consultations.
What happens when I stop taking GLP-1 medication?
Weight regain is common after stopping GLP-1 medications — clinical studies show most patients regain a significant portion of lost weight within 1–2 years of discontinuation. This doesn't mean the medication "failed" — it means GLP-1s address appetite and metabolic signals that return when the drug is removed. Many patients choose to stay on maintenance doses long-term. If you plan to stop, work with your prescriber on a gradual taper and have a plan for maintaining dietary and lifestyle habits that supported your progress.